AU2003241366A1 - Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer - Google Patents

Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer Download PDF

Info

Publication number
AU2003241366A1
AU2003241366A1 AU2003241366A AU2003241366A AU2003241366A1 AU 2003241366 A1 AU2003241366 A1 AU 2003241366A1 AU 2003241366 A AU2003241366 A AU 2003241366A AU 2003241366 A AU2003241366 A AU 2003241366A AU 2003241366 A1 AU2003241366 A1 AU 2003241366A1
Authority
AU
Australia
Prior art keywords
fluid
alloxazines
mitochondrial enhancer
endogenous
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003241366A
Other languages
English (en)
Inventor
Larry Joe Dumont
Raymond P. Goodrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo BCT Inc
Original Assignee
Gambro Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gambro Inc filed Critical Gambro Inc
Publication of AU2003241366A1 publication Critical patent/AU2003241366A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
AU2003241366A 2002-05-06 2003-05-06 Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer Abandoned AU2003241366A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37837402P 2002-05-06 2002-05-06
US60/378,374 2002-05-06
PCT/US2003/014070 WO2003094979A1 (en) 2002-05-06 2003-05-06 Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer

Publications (1)

Publication Number Publication Date
AU2003241366A1 true AU2003241366A1 (en) 2003-11-11

Family

ID=29420391

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003241366A Abandoned AU2003241366A1 (en) 2002-05-06 2003-05-06 Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer

Country Status (5)

Country Link
EP (1) EP1503806A1 (de)
JP (1) JP2005524714A (de)
AU (1) AU2003241366A1 (de)
CA (1) CA2483046A1 (de)
WO (1) WO2003094979A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111549079A (zh) * 2020-06-18 2020-08-18 内蒙古金达威药业有限公司 一种采用微生物发酵法制备维生素k2的方法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090023130A1 (en) * 2003-02-28 2009-01-22 Caridianbct Biotechnologies, Llc Prevention of Transfusion Related Acute Lung Injury Using Riboflavin and Light
WO2007067482A2 (en) * 2005-12-06 2007-06-14 Navigant Biotechnologies, Llc Method for treatment and storage of blood and blood products using endogenous alloxazines and acetate
CN112316166B (zh) * 2020-10-30 2022-07-12 中国医学科学院输血研究所 一种生物液体样本中病原体的核黄素光化学灭活方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403124B1 (en) * 1997-04-16 2002-06-11 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Storage and maintenance of blood products including red blood cells and platelets
US6258577B1 (en) * 1998-07-21 2001-07-10 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers
US7094378B1 (en) * 2000-06-15 2006-08-22 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US6268120B1 (en) * 1999-10-19 2001-07-31 Gambro, Inc. Isoalloxazine derivatives to neutralize biological contaminants
TW590780B (en) * 2000-06-02 2004-06-11 Gambro Inc Additive solutions containing riboflavin

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111549079A (zh) * 2020-06-18 2020-08-18 内蒙古金达威药业有限公司 一种采用微生物发酵法制备维生素k2的方法
CN111549079B (zh) * 2020-06-18 2024-05-10 内蒙古金达威药业有限公司 一种采用微生物发酵法制备维生素k2的方法

Also Published As

Publication number Publication date
JP2005524714A (ja) 2005-08-18
WO2003094979A1 (en) 2003-11-20
CA2483046A1 (en) 2003-11-20
EP1503806A1 (de) 2005-02-09

Similar Documents

Publication Publication Date Title
US11911471B2 (en) Anaerobic blood storage and pathogen inactivation method
EP1345491B1 (de) Photosensibilisator-enthaltende lagerungslösung zur inaktivierung von biologischen verunreinigungen
US20030228564A1 (en) Nitric oxide in a pathogen inactivation process
US7220747B2 (en) Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
US7901673B2 (en) Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
JP2004520448A (ja) 酸化防止剤を使用するウイルスの不活性化法
AU2003241366A1 (en) Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
US20230015525A1 (en) Anaerobic Blood Storage and Pathogen Inactivation Method
CA2495909C (en) Nucleic acid damage using riboflavin and light
WO2003089016A1 (en) Addition of glycolysis inhibitor to a pathogen reduction and storage solution

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application
TH Corrigenda

Free format text: IN VOL 18, NO 2, PAGE(S) 514 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME GAMBRO,INC., APPLICATION NO. 2003241366, UNDER INID (43) CORRECT THE PUBLICATION DATE TO READ 24.11.2003